19-Norpregna-1,3,5(10)-triene-11,20-dione,2-(b-D-glucopyranosyloxy)-3,16-dihydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI) (151703-10-5)

Identification
Name:	19-Norpregna-1,3,5(10)-triene-11,20-dione,2-(b-D-glucopyranosyloxy)-3,16-dihydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
Synonyms:	AndirobicinB glucoside; Cayaponoside C2
CAS:	151703-10-5
Molecular Formula:	C29H40 O10
Molecular Weight:	0
InChI:	InChI=1/C29H40O10/c1-12-14-6-7-19-27(3)9-16(32)21(13(2)31)28(27,4)10-20(33)29(19,5)15(14)8-17(22(12)34)38-26-25(37)24(36)23(35)18(11-30)39-26/h8,16,18-19,21,23-26,30,32,34-37H,6-7,9-11H2,1-5H3/t16-,18-,19+,21+,23-,24+,25-,26-,27?,28-,29+/m1/s1
Molecular Structure:
Properties
Flash Point:	249.1°C
Boiling Point:	764°C at 760 mmHg
Density:	1.395g/cm³
Refractive index:	1.622
Flash Point:	249.1°C
Safety Data

Other Product

19-Norpregna-1,3,5(10),6-tetraene-11,20-dione,2-(b-D-glucopyranosyloxy)-3,16-dihydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
19-Norcholesta-1,3,5(10)-triene-11,22-dione,25-(acetyloxy)-2-(b-D-glucopyranosyloxy)-3,16,20-trihydroxy-4,9,14-trimethyl-, (9b,16a)- (9CI)
19-Norcholesta-3,5,23-triene-2,11-dione,3-(b-D-glucopyranosyloxy)-16,20,22,25-tetrahydroxy-4,9,14-trimethyl-,(9b,10a,16a,23E)- (9CI)
19-Norcholesta-3,5,24-triene-2,11-dione,3-(b-D-glucopyranosyloxy)-16,20,22-trihydroxy-4,9,14-trimethyl-,(9b,10a,16a)- (9CI)
19-Norcholesta-3,5,25-triene-2,11-dione,3-(b-D-glucopyranosyloxy)-16,20,22-trihydroxy-4,9,14-trimethyl-,(9b,10a,16a)- (9CI)
19-Norcholesta-1,3,5(10)-triene-11,22-dione,2-(b-D-glucopyranosyloxy)-3,16,20,25-tetrahydroxy-4,9,14-trimethyl-,(9b,16a)-
19-Norpregna-1,3,5(10)-triene-11,20-dione,2,3,16-trihydroxy-4,9,14-trimethyl-, (9b,16a)- (9CI)
19-Norlanosta-1,5,23-triene-3,11,22-trione,2-(b-D-glucopyranosyloxy)-16,20-dihydroxy-9-methyl-,(9b,10a,16a,22E)- (9CI)
19-Norpregn-5-ene-11,20-dione,3-(b-D-glucopyranosyloxy)-2,16-dihydroxy-4,4,9,14-tetramethyl-,(2b,3a,9b,10a,16a)- (9CI)
19-Norlanost-5-ene-11,22-dione,20,24-epoxy-3-(b-D-glucopyranosyloxy)-16,25-dihydroxy-9-methyl-,(3a,9b,10a,16a,24S)- (9CI)
19-Norcholesta-1,3,5(10),23-tetraen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22,25-pentahydroxy-4,9,14-trimethyl-,(9b,16a,23E)- (9CI)
19-Norcholesta-1,3,5(10),24-tetraen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22-tetrahydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
19-Norcholesta-1,3,5(10)-trien-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22,25-pentahydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
19-Norcholesta-1,3,5(10),23,25-pentaen-11-one,2-(b-D-glucopyranosyloxy)-3,16,20,22-tetrahydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
19-Norcholesta-1,3,5(10)-trien-11-one,22,25-epoxy-2-(b-D-glucopyranosyloxy)-3,16,20-trihydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
19-Norcholesta-1,3,5(10),23-tetraene-11,22-dione,2-(b-D-glucopyranosyloxy)-3,16,20,25-tetrahydroxy-4,9,14-trimethyl-,(9b,16a,23E)- (9CI)
19-Norcholesta-1,3,5(10),25-tetraene-11,22-dione,2-(b-D-glucopyranosyloxy)-3,16,20-trihydroxy-4,9,14-trimethyl-,(9b,16a)- (9CI)
B(9a)-Homo-19-norpregna-9(11),9a,16-trien-20-one, 3-(dimethylamino)-4, 4,14-trimethyl-, (3beta,5alpha)-
19-Norcholesta-3,5-diene-2,11,22-trione,25-(acetyloxy)-3-(b-D-glucopyranosyloxy)-16,20-dihydroxy-4,9,14-trimethyl-, (9b,10a,16a)- (9CI)
19-Norlanosta-5,23-diene-11,22-dione,20,24-epoxy-3-(b-D-glucopyranosyloxy)-2,16-dihydroxy-9-methyl-,(2b,3a,9b,10a,16a)- (9CI)